The report "Active Pharmaceutical Ingredients Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020", The global Active Pharmaceutical Ingredients market is expected to reach USD 205.51 Billion by 2020 from USD 150 Billion in 2015, at a CAGR of 6.5% during the forecast period.

Browse 121 market data tables and 56 figures spread through 206 pages and in-depth TOC on “Active Pharmaceutical Ingredients Market”http://www.marketsandmarkets.com/Market-Reports/API-Market-263.htmlEarly buyers will receive 10% customization on report.

The report segments the APIs market based on types, type of manufacturer, type of synthesis, therapeutic area and regions. On the basis of type, the market is segmented into innovative and generic APIs. The innovative APIs segment is expected to account for the largest share of APIs market, by type, in 2015.

Among the type of manufacturer, the merchant APIs segment is expected to grow at the highest CAGR during the forecast period. Complexity and high expenses associated with in-house manufacturing of APIs as well as the increased competition from emerging contract manufacturers are propelling the growth of this segment.

Talk to Our Research Analysts for More Info@http://www.marketsandmarkets.com/speaktoanalyst.asp?id=263

Increasing global incidence of lifestyle and age-related diseases as well as cancer, technological advances in APIs manufacturing, increased awareness among people for better personal healthcare, government initiatives to increase availability and accessibility for better healthcare, and development of biologics and high potency APIs are propelling the growth of APIs market. On the other hand, the, stringent regulatory requirements and global economic recession may restrict market growth.

On the basis of region, the APIs market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2015 and will continue to dominate the market during the forecast period. The Asian market is poised to grow at the highest CAGR, mainly due to low labor and manufacturing costs, increasing disposable income, increasing population with lifestyle and age related diseases and governmental emphasis on healthcare reforms.

Get The Sample Copy Of This Report:http://www.marketsandmarkets.com/requestsample.asp?id=263

The APIs market is highly fragmented and competitive, with several big as well as emerging market players. Key market players include Teva Pharmaceuticals limited (Israel), Sun Pharmaceuticals Industries Limited (India), Dr. Reddy’s Laboratories Ltd. (India), Aurobindo (India), Novartis International AG (Switzerland), Boehringer Ingelheim (Germany), Albemarle Corporation (U.S.), Sigma-Aldrich (U.S.), Mylan (U.K.), Allergan plc.(Ireland).

Browse Related Reports:Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home Care Setting) - Global Forecast to 2020.http://www.marketsandmarkets.com/Market-Reports/injectable-drug-delivery-market-150.html

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020.http://www.marketsandmarkets.com/Market-Reports/biosimilars-40.html

About MarketsandMarkets:MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:Mr. RohanUnit No. 802, 8th Floor, Tower - 7, Magarpatta City SEZ,Hadapsar, Pune – 411013, Maharashtra, India.Tel: +1-888-6006-441.Email: sales@marketsandmarkets.comVisit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticalsConnect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets